Parkinson's Disease: Pathophysiology, Symptoms & Nursing Care
This paper provides a comprehensive overview of Parkinson's disease, a degenerative neurological disorder affecting approximately one million Americans. Beginning with the pathophysiology of dopaminergic neuron loss in the substantia nigra, the paper examines competing etiological theories including oxidative stress, accelerated aging, environmental neurotoxins, and genetic predisposition. It then surveys the disease's hallmark symptoms—tremor, bradykinesia, muscular rigidity, and cognitive decline—along with serious complications such as depression, dysphagia, and autonomic dysfunction. Medical treatment options, including stereotactic surgery, deep brain stimulation, and pharmacological agents such as levodopa and COMT inhibitors, are reviewed. The paper concludes by outlining the essential role of nursing care in long-term patient management.
- Introduction: Prevalence, demographics, and paper scope
- Pathophysiology of Parkinson's Disease: Dopamine loss and basal ganglia dysfunction
- Etiology: Oxidative stress, aging, toxins, and genetics
- Symptoms and Complications: Tremor, bradykinesia, dementia, and autonomic effects
- Medical Treatment: Surgical procedures and pharmacological agents
- Patient Education and Nursing Care: Long-term nursing interventions and patient management
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from cellular mechanisms to clinical presentation to treatment and finally to nursing management, giving readers a complete clinical picture rather than a fragmented one.
- Technical terminology (bradyphrenia, kyphosis, pallidotomy, COMT inhibitors) is consistently paired with plain-language explanations, making the content accessible without sacrificing accuracy.
- The nursing care section connects directly to earlier clinical content—for example, linking the constipation symptom discussed earlier to specific nursing interventions—demonstrating purposeful integration across sections.
Key academic technique demonstrated
The paper exemplifies systematic clinical organization: each pathophysiological concept is introduced before its symptomatic or therapeutic consequence appears, so every treatment rationale is already grounded in mechanism. For instance, the explanation of the dopamine–acetylcholine imbalance in the pathophysiology section directly underpins the later discussion of anticholinergic drug use, showing how mechanistic reasoning can structure an entire clinical essay.
Structure breakdown
Six sections progress from epidemiological context → cellular pathophysiology → etiological theories → symptom and complication survey → surgical and pharmacological treatments → nursing and patient education. This mirrors the standard SOAP/clinical-report progression and gives the paper a professional, reference-like quality suitable for a nursing or allied-health course.
Introduction
Parkinson's disease is a neurological disorder primarily diagnosed in people aged 50 and above. This degenerative disease affects muscular movement, creates tremor, and increases postural rigidity. First described in 1817 by James Parkinson, the disease is prevalent throughout the world. In both the United States and the United Kingdom, around 2% of the elderly population is afflicted by this neurological disorder. In the U.S. alone there are approximately one million patients, and every year 50,000 new cases of Parkinsonism are diagnosed. Given the nation's high and growing proportion of elderly people, these figures may increase rapidly in the near future. A brief overview of the etiology, symptoms, treatment, patient care, and education helps illuminate the disease condition and its management.
Pathophysiology of Parkinson's Disease
Parkinson's disease is a disorder of the motor structures in the basal ganglia region of the brain. One of the observed features of the disease is the degeneration of neurons in the substantia nigra, which are responsible for producing dopamine. Dopamine is one of the body's most important neurotransmitters and plays a critical role in controlling physical movement. A balance between acetylcholine (another neurotransmitter) and dopamine is essential for maintaining normal motor function. A decrease in dopamine-producing neurons therefore creates an imbalance in the dopamine–acetylcholine ratio, resulting in the manifestation of symptoms. The loss of pigmentation in the substantia nigra region indicates damage to the dopaminergic neurons. The existence of Lewy bodies and damage to other neuronal regions are also observed features of the disease.
Bibliography
Dr. David Nicholl (2003, October 19). "Parkinson's Disease." MedWeb. Retrieved June 4, 2004.
Jeff Blackmer, MD (2004, May 20). "Parkinson Disease." eMedicine. Retrieved June 4, 2004.
Suzanne C. O'Connell Smeltzer, EdD, RN, FAAN, and Brenda G. Bare, RN, MSN. Medical-Surgical Nursing. Brunner & Suddarth, 10th Edition, pp. 1979–1983.
Susan M. Calne and Ajit Kumar. "Nursing Care of Patients with Late-Stage Parkinson's Disease." Journal of Neuroscience Nursing, October 2003, Volume 35, Number 5. Retrieved June 4, 2004.
Create your account
Always verify citation format against your institution’s current style guide requirements.